Collaborating for the Cause

Collaborating for the Cause

Moving pharmaceutical products from development into commercialization is no small feat. Doing so for a rare disease and improving speed to therapy is even more challenging — but, because of UBC’s unique solutions and strategic partnerships, it’s a challenge that we can take on.

Watch the video below to learn how the partnership and collaboration between UBC and Accredo Specialty Pharmacy optimized the patient pathway for an ultra-orphan product.

 

 

Learn more about UBC and Accredo’s big solutions for small patient populations at NORD's Rare Diseases and Orphan Products Breakthrough Summit October 17-18 in Arlington, Virginia. UBC’s Vice President of Patient Access & Engagement, Nicole Hebbert, and Accredo’s Vice President of Business Development, Rob Osborne, will discuss how optimizing the role of specialty pharmacies and Hubs helps break down barriers to access for rare-disease patients during their presentation at 11:30 EST on Tuesday, October 18th.